OR WAIT null SECS
© 2022 MJH Life Sciences and Pharmaceutical Executive. All rights reserved.
© 2022 MJH Life Sciences™ and Pharmaceutical Executive. All rights reserved.
London-Following a review of its own drug discovery capabilities, GlaxoSmithKline practically gave away its majority stake in Affymax to a group of venture capitalists led by Patricof.